Drugs & Targets FDA grants priority review to Omblastys in pediatric CNS/leptomeningeal metastasis from neuroblastoma June 03, 2022Vol.48 No.22
Drugs & Targets FDA grants Fast Track designation to PDS0101 + Keytruda in recurrent or metastatic HPV16-positive HNC June 03, 2022Vol.48 No.22
Drugs & Targets OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression June 03, 2022Vol.48 No.22
Drugs & Targets C2i Genomics, Karkinos Healthcare partner to bring AI-powered cancer R&D to India June 03, 2022Vol.48 No.22
Capitol Hill House Republicans seek information on “me-too” drugs developed in China May 27, 2022Vol.48 No.21By Alice Tracey
Capitol Hill Cancer groups ask for $4.1 billion increase for NIH, $850 million boost for NCI in FY23 May 27, 2022Vol.48 No.21By Alice Tracey
In Brief Koen van Besien named chief of Division of Hematology, director of Wesley Center for Immunotherapy at UH Seidman May 27, 2022Vol.48 No.21
In Brief Xiao-Jing Wang named chief science officer, associate director for basic science at UC Davis May 27, 2022Vol.48 No.21
